ITRAQ quantitative analysis of multidrug resistance mechanisms in human gastric cancer cells

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Hu, Huai Dong ^a   Ye, Feng ^a   Zhang, Da Zhi ^a   Hu, Peng ^a   Ren, Hong ^a   Li, Sang Lin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VINCRISTINE; LUNG RESISTANCE PROTEIN; RIBONUCLEOPROTEIN; SMALL INTERFERING RNA; TUMOR PROTEIN;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG ACTIVITY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MULTIDRUG RESISTANCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STOMACH CANCER; WESTERN BLOTTING; AMINO ACID SEQUENCE; CHEMISTRY; DRUG RESISTANCE; ISOTOPE LABELING; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PROTEOMICS; REPRODUCIBILITY; STOMACH TUMOR; TUMOR CELL LINE;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; ISOTOPE LABELING; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 77954550912     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/571343     Document Type: Article

References (34)

1. Parkin D. M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002 CA: A Cancer Journal for Clinicians 2005 55 2 74 108
2. Zhang D., Fan D., Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges Expert Review of Anticancer Therapy 2007 7 10 1369 1378
3. Dietel M., Molecular mechanisms and possibilities of overcoming drug resistance in gastrointestinal tumors Recent Results in Cancer Research 1996 142 89 101
4. Yang Y. X., Xiao Z. Q., Chen Z. C., Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR Proteomics 2006 6 6 2009 2021
5. Li X., Zhang Y., Xiong C., Overexpression of a new gene p28GANK confers multidrug resistance of gastric cancer cells Cancer Investigation 2009 27 2 129 139
6. Gorg A., Drews O., Luck C., Weiland F., Weiss W., 2-DE with IPGs Electrophoresis 2009 30 supplement 1 S122 S132
7. Weiss W., Grg A., Sample solublization buffers for two-dimensional electrophoresis Methods in Molecular Biology 2008 424 35 42
8. Hu L., Ye M., Zou H., Recent advances in mass spectrometry-based peptidome analysis Expert Review of Proteomics 2009 6 4 433 447
9. Leitner A., Lindner W., Chemical tagging strategies for mass spectrometry-based phospho-proteomics Methods in Molecular Biology 2009 527 229 243
10. Plumb J. A., Milroy R., Kaye S. B., Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay Cancer Research 1989 49 16 4435 4440
11. Guo T., Gan C. S., Zhang H., Zhu Y., Kon O. L., Sze S. K., Hybridization of pulsed-Q dissociation and collision-activated dissociation in linear ion trap mass spectrometer for iTRAQ quantitation Journal of Proteome Research 2008 7 11 4831 4840
12. Baumert C., Hilgeroth A., Recent advances in the development of P-gp inhibitors Anti-Cancer Agents in Medicinal Chemistry 2009 9 4 415 436
13. Dickenson N. E., Moore D., Suprenant K. A., Dunn R. C., Vault ribonucleoprotein particles and the central mass of the nuclear pore complex Photochemistry and Photobiology 2007 83 3 686 691
14. van Zon A., Mossink M. H., Scheper R. J., Sonneveld P., Wiemer E. A. C., The vault complex Cellular and Molecular Life Sciences 2003 60 9 1828 1837
15. Kickhoefer V. A., Rajavel K. S., Scheffer G. L., Dalton W. S., Scheper R. J., Rome L. H., Vaults are up-regulated in multidrug-resistant cancer cell lines Journal of Biological Chemistry 1998 273 15 8971 8974
16. Kitazono M., Okumura H., Ikeda R., Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells International Journal of Cancer 2001 91 1 126 131
17. Siva A. C., Raval-Fernandes S., Stephen A. G., Up-regulation of vaults may be necessary but not sufficient for multidrug resistance International Journal of Cancer 2001 92 2 195 202
18. Mossink M. H., van Zon A., Franzel-Luiten E., Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics Cancer Research 2002 62 24 7298 7304
19. de la Pena M., Dufour D., Gallego J., Three-way RNA junctions with remote tertiary contacts: a recurrent and highly versatile fold RNA 2009 15 11 1949 1964
20. Wool I. G., Chan Y. L., Gluck A., Structure and evolution of mammalian ribosomal proteins Biochemistry and Cell Biology 1995 73 11-12 933 947
21. Shi Y., Zhai H., Wang X., Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis Experimental Cell Research 2004 296 2 337 346
22. Johnsson A., Zeelenberg I., Min Y., Identification of genes differentially expressed in association with acquired cisplatin resistance British Journal of Cancer 2000 83 8 1047 1054
23. Yang Y. X., Chen Z. C., Zhang G. Y., Yi H., Xiao Z. Q., A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line Journal of Cellular Biochemistry 2008 104 3 1010 1021
24. Lacana E., Ganjei J. K., Vito P., D'Adamio L., Dissociation of apoptosis and activation of IL-1 -converting enzyme/ced-3 proteases by ALG-2 and the truncated Alzheimer's gene ALG-3 Journal of Immunology 1997 158 11 5129 5135
25. Vito P., Lacan E., D'Adamio L., Interfering with apoptosis: Ca2+ -binding protein ALG-2 and Alzheimer's disease gene ALG-3 Science 1996 271 5248 521 525
26. Hoj B. R., la Cour J. M., Mollerup J., Berchtold M. W., ALG-2 knockdown in HeLa cells results in G2/M cell cycle phase accumulation and cell death Biochemical and Biophysical Research Communications 2009 378 1 145 148
27. Abu-Hadid M., Wilkes J. D., Elakawi Z., Pendyala L., Perez R. P., Relationship between heat shock protein 60 (HSP6O) mRNA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell lines Cancer Letters 1997 119 1 63 70
28. Morrison D. K., The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development Trends in Cell Biology 2009 19 1 16 23
29. Qi W., Liu X., Chen W., Li Q., Martinez J. D., Overexpression of 14-3-3 causes polyploidization in H322 lung cancer cells Molecular Carcinogenesis 2007 46 10 847 856
30. Hermeking H., Lengauer C., Polyak K., 14-3-3 is a p53-regulated inhibitor of G2/M progression Molecular Cell 1997 1 1 3 11
31. Qi W., Martinez J. D., Reduction of 14-3-3 proteins correlates with increased sensitivity to killing of human lung cancer cells by ionizing radiation Radiation Research 2003 160 2 217 223
32. Helleman J., Jansen M. P., Span P. N., Molecular profiling of platinum resistant ovarian cancer International Journal of Cancer 2006 118 8 1963 1971
33. Nicholson L. J., Smith P. R., Hiller L., Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer International Journal of Cancer 2009 125 6 1454 1463
34. Naito S., Yokomizo A., Koga H., Mechanisms of drug resistance in chemotherapy for urogenital carcinoma International Journal of Urology 1999 6 9 427 439